Key result
Alcohol septal ablation produces no immediate change in coronary flow reserve in HOCM patients.
Why the study?
Hypertrophic cardiomyopathy is associated with coronary microvascular dysfunction showing variable pathophysiologic mechanisms and variable reversibility acutely and chronically following alcohol septal ablation.
Does alcohol septal ablation improve immediate absolute coronary blood flow and coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy?
Observational (n=23)
No
Does alcohol septal ablation improve immediate absolute coronary blood flow and coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy?
Alcohol septal ablation in hypertrophic obstructive cardiomyopathy does not produce immediate uniform improvements in coronary microvascular function, though a subset with lower baseline flow may experience improvement.
Answers are grounded in this paper and cite their sources.
No immediate change in coronary flow reserve after alcohol septal ablation; leaves open whether delayed effects or clinical outcomes differ in hypertrophic obstructive cardiomyopathy.
BACKGROUND: Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA). AIMS: The aim of this study was to examine immediate changes in absolute coronary blood flow before and after ASA using continuous thermodilution. METHODS: Consecutive eligible patients without obstructive coronary artery disease undergoing ASA in a single center were enrolled in the study. Absolute coronary blood flow (Q) was measured using continuous thermodilution technique before and immediately after ASA and was used to calculate coronary flow reserve (CFR) and resistance (R). RESULTS: Twenty-three patients, aged 57.9 ± 12.6 years, 47.8% female, underwent ASA. Left ventricular outflow tract gradient decreased from a median of 101 mmHg [IQR 77-133] to a median of 19 mmHg [16-36 mmHg] (p < 0.01). Comparing the state before and after ASA, no changes were observed in average resting (0.126 ± 0.064 vs. 0.129 ± 0.081 L/min) or hyperemic (0.264 ± 0.136 vs. 0.248 ± 0.116 L/min) coronary blood flow, or between resting (868 ± 564 vs. 929 ± 618 mmHg/[L/min]) or hyperemic (351 ± 172 vs. 345 ± 126 mmHg/[L/min]) resistance (p > 0.05 for all). The majority of patients n = 16 (69.6%) had an abnormal CFR (≤ 2.5) prior to ASA. Mean CFR was 2.31 ± 1.02 before and 2.35 ± 1.04 after ASA (p = 0.808 for difference). Thirteen patients experienced CFR improvement by 10%, and they had significantly lower hyperemic Q (0.219 ± 0.087 vs. 0.336 ± 0.171 L/min, p = 0.041) and CFR (1.86 ± 0.76 vs. 2.85 ± 1.19, p = 0.041) before ASA, compared to those who didn't. CONCLUSIONS: Patients with obstructive hypertrophic cardiomyopathy are a heterogeneous population with variable immediate microvascular response to ASA.
No takes yet. Share an insight, caveat, or question.
Misevic et al. (2026) conducted an observational in Hypertrophic Obstructive Cardiomyopathy (n=23). Alcohol Septal Ablation vs. Pre-ablation baseline was evaluated on Coronary flow reserve (CFR) (p=0.808). Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy produced no significant immediate change in mean coronary flow reserve.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: